<?xml version="1.0" encoding="UTF-8"?>
<p id="Par45">Two prospective European surveys, probably considering only the most severe cases, estimated the mortality linked to the 2009 AH1N1 pandemic in HSCT patients to be 6.3% [
 <xref ref-type="bibr" rid="CR2">2</xref>]. The incidence of influenza in hematological and/or transplant patients varies, according to the study, from very low to medium; nonetheless, the aforementioned virus remains a significant cause of morbidity and mortality [
 <xref ref-type="bibr" rid="CR6">6</xref>] (Table 
 <xref rid="Tab1" ref-type="table">1</xref>). Nichols et al. report that the incidence in HSCT patients ranges between 1 and 3% [
 <xref ref-type="bibr" rid="CR27">27</xref>].
</p>
